Abstract:DISCLAIMER In an effort to expedite the publication of articles, AJHP is posting manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time. PURPOSE Proton pump inhibitors (PPIs) are widely prescribed medications. Various adverse clinical effects of PPIs have been reported in the literature, particularly over the past decade. The purpose of this article is to review published data primarily describing adverse effects associated with PPI use and to help clinicians determine which patients may still benefit from therapy despite safety concerns. SUMMARY Associations between PPIs and the following have been described: bone fracture, acute and chronic kidney disease, gastrointestinal infections, deficiencies in vitamin B12 and magnesium, and coronavirus disease 2019 and respiratory infections. For inclusion in this review, studies must have evaluated potential adverse events associated with PPIs as a primary or secondary objective. Increased risks of bone fracture, acute and chronic kidney disease, gastrointestinal infections, and magnesium deficiency were consistently reported, albeit mostly in studies involving low-quality data (case-control and/or observational studies) and subject to bias. In the only pertinent randomized controlled trial to date, chronic pantoprazole use was associated with a greater risk of enteric infections relative to placebo use; there was no significant between-group difference in any other adverse event evaluated. PPIs continue to be recommended by the American College of Gastroenterology as a first-line treatment for management of gastroesophageal reflux disease and in the acute period following upper gastrointestinal and ulcer bleeding. CONCLUSION Higher-quality data is needed to better understand PPI-associated risks of the adverse effects listed above. Until then, clinicians may consider greater vigilance with PPI use; however, the data does not demonstrate a need for wide adoption of de-escalation strategies solely out of safety concerns.

Adverse events in patients with cardiovascular disease taking proton pump inhibitors

Adverse reactions of proton pump inhibitors

Proton pump inhibitors and cardiovascular adverse events: a meta-analysis of randomized controlled trials

Adverse cardiovascular outcomes associated with proton pump inhibitor use after percutaneous coronary intervention: a systematic review and meta-analysis

Cardiovascular and non-cardiovascular concerns with proton pump inhibitors: Are they safe?

Focus on Safety of Proton Pump Inhibitors

Long-term Use of Proton Pump Inhibitors is Associated with an Increased Risk of Nonalcoholic Fatty Liver Disease

Adverse Effects Associated with Long-Term Use of Proton Pump Inhibitors

The Association of Long-Term Use of Proton Pump Inhibitors and Histamine H2 Receptor Antagonists with Clinical Complications in Patients with Severe Sepsis

A Review of the Novel Application and Potential Adverse Effects of Proton Pump Inhibitors

Understanding the health risks and emerging concerns associated with the use of long-term proton pump inhibitors

Proton pump inhibitors: Understanding the associated risks and benefits of long-term use.

Current situation of progress in long-term use of proton pump inhibitors may increase the risk of dementia

Proton pump inhibitors from clinical pharmacists point of view

Long Term Risks of Proton Pump Inhibitor Administration: A Literature Review

Emerging Long-Term Risks of the Use of Proton Pump Inhibitors and Potassium-Competitive Acid Blockers

Proton Pump Inhibitor Use and Worsening Kidney Function: A Retrospective Cohort Study Including 122,606 Acid-Suppressing Users

Association between Proton Pump Inhibitor Use and Risk of Incident Chronic Kidney Disease: Systematic Review and Meta-Analysis

Acid suppressants use and risk of atherosclerotic cardiovascular disease in middle-aged and older adults

Adverse effects of proton pump inhibitors (PPIs) on the renal system using data mining algorithms (DMAs)

Association between regular proton pump inhibitors use and cardiovascular outcomes: A large prospective cohort study